Welcome to the Cardio-Renal-Metabolic Hub, Boehringer Ingelheim's resource portal for UK Healthcare Professionals

Your partner in daily practice and patient consultation

 

Explore the Cardio-Renal-Metabolic Hub

Explore the Cardio-Renal-Metabolic Hub

With you and your patients in mind, we've created the Cardio-Renal-Metabolic hub please click below to find resources pertaining to heart failure, chronic kidney disease and type 2 diabetes, including management with JARDIANCE® (empagliflozin).

The content on this website is in relation to adult patients.

Quick links

Quick links

JARDIANCE® (empagliflozin)

Resource areas

Read more
JARDIANCE (empagliflozin) logo

JARDIANCE® T2D resources

Resources for healthcare professionals in their management of T2D patients
Learn more
Read more
JARDIANCE (empagliflozin) logo

JARDIANCE® Heart Failure resources

Resources for healthcare professionals in their management of heart failure patients
Learn more
Read more
JARDIANCE (empagliflozin) logo

JARDIANCE® Chronic Kidney Disease resources

Resources for healthcare professionals in their management of chronic kidney disease patients
Learn more
BI Lilly Alliance Logo

PC-GB-109250 V2

February 2024

Reporting adverse events

Adverse events should be reported. Reporting form and information can be found atwww.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on0800 328 1627 (freephone).

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.